Option Care Health, Inc. (NASDAQ:OPCH) Shares Purchased by State of Alaska Department of Revenue

State of Alaska Department of Revenue increased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 2.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,931 shares of the company’s stock after acquiring an additional 525 shares during the quarter. State of Alaska Department of Revenue’s holdings in Option Care Health were worth $696,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Option Care Health by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company’s stock valued at $448,118,000 after purchasing an additional 75,313 shares during the last quarter. Wellington Management Group LLP boosted its holdings in Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after purchasing an additional 8,400,208 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company’s stock valued at $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Northern Trust Corp boosted its holdings in Option Care Health by 11.8% in the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company’s stock valued at $60,934,000 after purchasing an additional 278,158 shares during the last quarter. Finally, Norges Bank acquired a new position in Option Care Health in the 4th quarter valued at about $60,219,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Up 0.8%

Option Care Health stock opened at $32.25 on Friday. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock’s fifty day simple moving average is $32.06 and its 200-day simple moving average is $30.88. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. The firm has a market capitalization of $5.28 billion, a P/E ratio of 26.01, a P/E/G ratio of 1.95 and a beta of 0.74.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The company’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.26 earnings per share. As a group, equities analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on OPCH. UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Barrington Research reissued an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. Finally, JMP Securities reissued a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a research report on Wednesday, June 18th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.